Assignee
JANSSEN PHARMACEUTICALS INC
US·120 granted patents·97 pending applications·552 citations·filing 2005–2025
Top patents by PatentIndex Score
217 records- 0196US11364310B2Recombinant virus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 21, 2022·12 cites·18 claims
- 0296US11266627B1Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·12 cites·30 claims
- 0395US11998525B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Jun 4, 2024·5 cites·29 claims
- 0495USD956215SAutoinjectorJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Jun 28, 2022·19 cites·1 claims
- 0595US10919854B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 16, 2021·3 cites·28 claims
- 0695USD903108SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 24, 2020·19 cites·1 claims
- 0795US9944598B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 17, 2018·21 cites·17 claims
- 0895US9605082B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Mar 28, 2017·11 cites·24 claims
- 0994US12150929B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Nov 26, 2024·2 cites·19 claims
- 1094US11827602B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 28, 2023·2 cites·11 claims
- 1194US11083786B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·13 cites·24 claims
- 1294US11033633B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·11 cites·20 claims
- 1394US10029984B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·21 cites·5 claims
- 1493US12161622B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·2 cites·29 claims
- 1593US11607216B2Adaptive responses from smart packaging of drug delivery absorbable adjunctsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Mar 21, 2023·4 cites·26 claims
- 1693US11498944B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·10 cites·28 claims
- 1793US8399493B2Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptorsJANSSEN PHARMACEUTICALS INC·Filed 2005·Granted Mar 19, 2013·50 cites·9 claims
- 1892US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
- 1992US11421003B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Aug 23, 2022·4 cites·25 claims
- 2092US11124552B2Compositions of phosphorylated tau peptides and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Sep 21, 2021·8 cites·14 claims
- 2192USD902392SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·13 cites·1 claims
- 2292US10206902B2Mono- or di-substituted indoles as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Feb 19, 2019·14 cites·9 claims
- 2392US10159751B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Dec 25, 2018·16 cites·20 claims
- 2492US9981950B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·17 cites·28 claims
- 2592US9518128B2Thrombin-binding antibody moleculesJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Dec 13, 2016·10 cites·27 claims
- 2691US12012435B2FimH mutant, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Jun 18, 2024·2 cites·15 claims
- 2791US11844766B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Dec 19, 2023·2 cites·22 claims
- 2891US11384122B2Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Jul 12, 2022·2 cites·30 claims
- 2991US10696632B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 30, 2020·3 cites·13 claims
- 3091US10525145B2ExPEC glycoconjugate vaccine formulationsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jan 7, 2020·11 cites·30 claims
- 3191US10323021B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jun 18, 2019·13 cites·32 claims
- 3290US11725028B2FimH mutants, compositions therewith and use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Aug 15, 2023·3 cites·33 claims
- 3390USD946141SAutoinjectorJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·27 cites·1 claims
- 3490USD902391SGrip accessory for a manual injection deviceJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·11 cites·1 claims
- 3590US10538786B2Recombinant arterivirus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·14 cites·28 claims
- 3689US11180450B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 3789US10689340B2Substituted indoline derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 23, 2020·4 cites·8 claims
- 3889US10155727B2PyrazolesJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·15 cites·32 claims
- 3989US10143693B2Dosing regimen for missed doses for long-acting injectable paliperidone estersJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Dec 4, 2018·31 cites·29 claims
- 4088US12419859B2Compositions and methods for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2024·Granted Sep 23, 2025·0 cites·7 claims
- 4188US12172959B2Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·27 claims
- 4288US11591377B2Heterologous administration of tau vaccinesJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Feb 28, 2023·2 cites·20 claims
- 4388US9988461B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jun 5, 2018·3 cites·31 claims
- 4488US9518129B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2012·Granted Dec 13, 2016·9 cites·25 claims
- 4588US2025230127A1Mono- or di-substituted indole derivatives as dengue viral replication inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4687US11826416B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·1 cites·24 claims
- 4785US12173025B2Substituted nucleosides, nucleotides and analogs thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 4885US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
- 4984US11707440B2Esketamine for the treatment of depressionJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jul 25, 2023·4 cites·17 claims
- 5084US9988463B2Thrombin-binding antibody molecules and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2016·Granted Jun 5, 2018·3 cites·21 claims
Showing the top 50 of 217 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →